NeurologyWire

FDA Approves Migraine Drug For Pediatric Patients

From NeurologyWire

FDA has approved Treximet (sumatriptan and naproxen sodium) for use in pediatric patients 12 years of age and older for the acute treatment of migraine with or without aura.It is the first approved combination prescription medicine, and the first to contain sumatriptan, for the treatment of acute migraine attacks in pediatric patients. The two medi...

Login to read story

Thursday, June 25, 2015

Show last days of articles

Low Scores on Memory and Thinking Tests May Signal Alzheimer...

From NeurologyWire

A new study suggests that errors on memory and thinking tests may signal Alzheimers up to 18 years before the disease can be diagnosed. The research i...Full story

Multiple Cortical Regions Work Together to Process Sensorimo...

From NeurologyWire

Neuroscientists show that multiple cortical regions are needed to process information.Researchers at MIT say they have proven that the brains cortex d...Full story

Two FDA-Approved Mini-Probes Launch

From NeurologyWire

Monteris Medical has launched two new reduced diameter mini-probes for its NeuroBlate System, a minimally invasive robotic laser thermotherapy tool.Th...Full story

AMA Issues Support for SCOTUS Ruling

From NeurologyWire

From the American Medical Association, regarding the Supreme Court's ruling in favor of the Obama administration in King v. Burwell:"The American Medi...Full story

Wednesday, June 24, 2015

Fat, Sugar Cause Bacterial Changes That May Relate to Loss o...

From NeurologyWire

A study at Oregon State University indicates that both a high-fat and a high-sugar diet, compared to a normal diet, cause changes in gut bacteria that...Full story

Brain Connectivity Study Could Lead to Better Outcomes for E...

From NeurologyWire

A new study found that patients with epilepsy have significantly weaker connections throughout their brain, particularly in regions important for atte...Full story

Small Bowel Feeding Bests Gastric Feeding For Severe TBI, Ne...

From NeurologyWire

While there is no consensus for the preferred route of feeding following severe traumatic brain injury (TBI), new evidence suggests that small bowel f...Full story

Tuesday, June 23, 2015

Parkinsons Patients Have Worse Eyesight than Healthy Patient...

From NeurologyWire

Patients with Parkinson's had significantly worse vision for low contrast images at near and far distances, according to research published in the Jou...Full story

Participating in Online Health Community May Help People Man...

From NeurologyWire

Participating in an online patient community may help people with epilepsy better manage the disease, according to a study published in the June 17, 2...Full story

FDA to Hold Meeting For Patients on Drug Development for Hun...

From NeurologyWire

FDA will hold a public meeting for patients regarding the drug development for Huntingtons disease and Parkinsons disease. "The public meeting is int...Full story

Monday, June 22, 2015

Drug to Treat Cognitive Impairment in Schizophrenia Given Fa...

From NeurologyWire

FDA has granted Fast Track designation to encenicline, a developmental drug to treat cognitive impairment in schizophrenia. The FDAs Fast Track progra...Full story

FDA Expands Indication of Fycompa

From NeurologyWire

FDA has approved the anti-epilepsy drug Fycompa as an adjunctive treatment of primary generalized tonic-clonic (PGTC) seizures in patients with epilep...Full story

Trans Fat Linked to Worse Memory

From NeurologyWire

Higher consumption of dietary trans fatty acids (dTFA), commonly used in processed foods to improve taste, texture and durability, has been linked to ...Full story

Friday, June 19, 2015

Physical Activity May Improve Disability in MS

From 2015 Meeting of CMSC

When it comes to modifiable behaviors, increasing physical activity may have greater impact on disability in MS than do other behaviors like decreasin...Full story

NeuroDerm Poster Selected for Blue Ribbon Highlights Session...

From NeurologyWire

NeuroDerm Ltd's poster presentation, "Stable levodopa plasma levels with ND0612 (LD/CDfor subcutaneous infusion) in Parkinson's disease (PD) patients ...Full story